NASDAQ: SAVA
Cassava Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for SAVA

Based on 1 analyst offering 12 month price targets for Cassava Sciences Inc

Min Forecast
$2.00+28.21%
Avg Forecast
$2.00+28.21%
Max Forecast
$2.00+28.21%

Should I buy or sell SAVA stock?

Based on 1 analyst offering ratings for Cassava Sciences Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their SAVA stock forecasts and price targets.

SAVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-25

1 of 1

Forecast return on equity

Is SAVA forecast to generate an efficient return?

Company
N/A
Industry
142.9%
Market
80.27%

Forecast return on assets

Is SAVA forecast to generate an efficient return on assets?

Company
N/A
Industry
35.65%

SAVA earnings per share forecast

What is SAVA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.55

SAVA revenue forecast

What is SAVA's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$100.0M

SAVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAVA$1.56$2.00+28.21%Hold
IVVD$0.63$7.52+1,093.17%Strong Buy
TELO$2.55N/AN/A
MNOV$1.52$9.00+492.11%Strong Buy
IMAB$0.94$5.50+485.11%Buy

Cassava Sciences Stock Forecast FAQ

Is Cassava Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SAVA) stock is to Hold SAVA stock.

Out of 1 analyst, 0 (0%) are recommending SAVA as a Strong Buy, 0 (0%) are recommending SAVA as a Buy, 1 (100%) are recommending SAVA as a Hold, 0 (0%) are recommending SAVA as a Sell, and 0 (0%) are recommending SAVA as a Strong Sell.

If you're new to stock investing, here's how to buy Cassava Sciences stock.

What is SAVA's earnings growth forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Cassava Sciences's earnings in 2025 is -$24,342,000.

In 2025, SAVA is forecast to generate -$26,569,343 in earnings, with the lowest earnings forecast at -$26,569,343 and the highest earnings forecast at -$26,569,343.

What is SAVA's revenue growth forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.

Cassava Sciences's revenue in 2025 is $0.

In 2025, SAVA is forecast to generate $4,830,789,600 in revenue, with the lowest revenue forecast at $4,830,789,600 and the highest revenue forecast at $4,830,789,600.

What is SAVA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SAVA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 35.65%.

What is SAVA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SAVA price target, the average SAVA price target is $2.00, with the highest SAVA stock price forecast at $2.00 and the lowest SAVA stock price forecast at $2.00.

The Wall Street analyst predicted that Cassava Sciences's share price could reach $2.00 by Mar 25, 2026. The average Cassava Sciences stock price prediction forecasts a potential upside of 28.21% from the current SAVA share price of $1.56.

What is SAVA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's current Earnings Per Share (EPS) is -$0.53. In 2025, SAVA's EPS is forecast to hit -$0.55 (min: -$0.55, max: -$0.55).

What is SAVA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SAVA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.